Calley Means, a top adviser to Health Secretary Robert F. Kennedy Jr. and a chief advocate for the Make America Healthy Again movement, resigned from his position with the Trump administration Thursday.

The report from congressional Democrats found that Trump's pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025.

Open enrollment comes as inflation adds pressure on seniors whose healthcare costs have risen and as midterm elections are weeks away. Voters have consistently said cost-of-living is a major concern.